Cancer incidence after retinoblastoma: Radiation dose and sarcoma risk

JAMA

Volumn 278, Issue 15, 1997, Pages 1262-1267

  Wong, F Lennie ^a,i   Boice, John D ^a,h   Abramson, David H ^c   Tarone, Robert E ^a   Kleinerman, Ruth A ^a   Stovall, Marilyn ^b   Goldman, Marlene B ^f   Seddon, Johanna M ^d,f   Tarbell, Nancy ^g   Fraumeni, Joseph F ^a   Li, Frederick P ^e,f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

ⁱ EPN ^*

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CHROMOSOME 19; CONTROLLED STUDY; ETHNIC GROUP; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

EID: 0030848527     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.15.1262     Document Type: Article

References (38)

1. Knudson AG Jr. Retinoblastoma: a prototypic hereditary neoplasm. Semin Oncol. 1978;5:57-60.
2. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retino-blastoma. J Natl Cancer Inst. 1993;85:1121-1128.
3. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 1988;95:1583-1587.
4. Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with hereditary retino-blastoma: a register-based follow-up study, 1945-1994. Int J Cancer. 1996;67:515-519.
5. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986;53:661-671.
6. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323:642-646.
7. Tucker MA, D'Angio GJ, Boice JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987;317:588-593.
8. Hawkins MM, Wilson LM, Burton HS, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst. 1996; 88:270-278.
9. World Health Organization. ICD-O: International Classification of Diseases for Oncology. Geneva, Switzerland: World Health Organization; 1976.
10. Monson RR. Analysis of relative survival and proportional mortality. Comput Biomed Res. 1969; 105:529-535.
11. Heston JF, Kelly JAB, Meigs JW, Flannery JT, Cusano MM, Young JL Jr. Forty-five years of cancer incidence in Connecticut: 1935-79. Natl Cancer Inst Monogr. 1986;70:1-706.
12. Boice JD Jr, Storm HH, Curtis RE, et al, eds. Multiple primary cancers in Connecticut and Denmark. Natl Cancer Inst Monogr. 1985;68:1-434.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
14. Preston DL, Lubin JH, Pierce DA. Epicure User's Guide. Seattle, Wash: Hirosoft International; 1991.
15. Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1:54-77.
16. Stovall M, Smith SA, Rosenstein M. Tissue doses from radiotherapy of cancer of the uterine cervix. Med Phys. 1989;16:726-733.
17. Pesin SR, Shields JA. Seven cases of trilateral retinoblastoma. Am J Ophthalmol. 1989;107:121-126.
18. Young JL, Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986;58:598-602.
19. Young JL, Perry CL, Asine AJ, eds. Surveillance, epidemiology and end results; incidence and mortality data. Natl Cancer Inst Monogr. 1981;57: 70-73.
20. Abramson DH, Ellsworth RM, David F, Tung G. Second non-ocular tumors in retinoblastoma survivors. Ophthalmology. 1984;91:1351-1355.
21. DerKinderen DJ, Koten JW, Wolterbeek R, Beemer FA, Tan KE, Den Otter W. Non-ocular cancer in hereditary retinoblastoma survivors and relatives. Ophthal Paediatr Genet. 1987;8:23-25.
22. Francois J, de Sutter E, Coppieters R, de Bie S. Late extraocular tumours in retinoblastoma survivors. Ophthalmologica. 1980;181:93-99.
23. Winther J, Olsen JH, de Nully Brown P. Risk of nonocular cancer among retinoblastoma patients and their parents: a population-based study in Denmark, 1943-1984. Cancer. 1988;62:1458-1462.
24. Bader JL, Meadows AT, Zimmerman LE, et al. Bilateral retinoblastoma with ectopic intracranial retinoblastoma: trilateral retinoblastoma. Cancer Genet Cytogenet. 1982;5:203-213.
25. Traboulsi EI, Zimmerman LE, Manz HJ. Cutaneous malignant melanoma in survivors of heritable retinoblastoma. Arch Ophthalmol. 1988;106:1059-1061.
26. Meadows AT, Baum E, Fossati-Bellani F. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol. 1985; 3:532-538.
27. Laskin WB, Silverman TA, Enzinger FM. Postradiation soft tissue sarcomas: an analysis of 53 cases. Cancer. 1988;62:2330-2340.
28. Ruka W, Sikorowa L, Iwanowska J, Romeyko M. Induced soft tissue sarcomas following radiation treatment for uterine carcinomas. Eur J Surg Oncol. 1991;17:585-593.
29. Kony SJ, de Vathaire F, Chompret A, et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet. 1997;350:91-95.
30. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors, part II: solid tumors, 1958-1987. Radiat Res. 1994;137:S17-S67.
31. Davis FG, Boice JD Jr, Hrubec Z, Monson RR. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 1989;49:6130-6136.
32. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR 1994 Report to the General Assembly, With Scientific Annexes: Sources and Effects of Ionizing Radiation. New York, NY: United Nations; 1994: Vol E.94.IX.11.
33. Robinson E, Neugut AI, Wylie P. Clinical aspects of postirradiation sarcomas. J Natl Cancer Inst. 1988;80:233-240.
34. Klein EA, Anzil AP, Mezzacappa P, Borderon M, Ho V. Sinonasal primitive neuroectodermal tumor arising in a long-term survivor of heritable unilateral retinoblastoma. Cancer. 1992;70:423-431.
35. Schifter S, Vendelbo L, Jensen OM, Kaae S. Ewing's tumor following bilateral retinoblastoma: a case report. Cancer. 1983;51:1746-1749.
36. Folberg R, Cleasby G, Flanagan JA, Spencer WH, Zimmerman LE. Orbital leiomyosarcoma after radiation therapy for bilateral retinoblastoma. Arch Ophthalmol. 1983;101:1562-1565.
37. Horowitz JM, Park SBH, Bogenmann E, et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci U S A. 1990;87:2775-2779.
38. Xu HBJ, Hu SBX, Cagle PT, Moore GE, Benedict WF. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res. 1991;51:2735-2739.